Jasper Therapeutics (JSPR) Change in Cash (2020 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Change in Cash of -$22.2 million for Q4 2025, down 6.43% year-over-year from -$23.7 million in Q4 2024, and down 294.99% quarter-over-quarter from $11.4 million in Q3 2025.
Jasper Therapeutics (JSPR) Change in Cash (2020 - 2025) Analysis & Trends
Jasper Therapeutics' Change in Cash history runs 6 years deep, the most recent figure standing at -$22.2 million for Q4 2025.
- In Q4 2025, Change in Cash fell 6.43% year-over-year to -$22.2 million; the TTM figure through Dec 2025 stood at -$42.9 million (down 181.61% YoY), while the FY2025 annual figure was -$42.9 million, down 181.61% from the prior year.
- Change in Cash for Q4 2025 stood at -$22.2 million, down from $11.4 million in the prior quarter.
- The five-year high for Change in Cash was $91.1 million in Q1 2023, with the low at -$22.8 million in Q1 2025.
- The 5-year median for Change in Cash is -$11.8 million (2023), against an average of $446300.0.
- Peak annual rise in Change in Cash reached 2412.29% in 2021, while the deepest fall reached 4571.69% in 2021.
- Jasper Therapeutics' Change in Cash stood at -$16.2 million in 2021, then grew by 21.62% to -$12.7 million in 2022, then tumbled by 33.7% to -$17.0 million in 2023, then slipped by 22.88% to -$20.9 million in 2024, then dropped by 6.43% to -$22.2 million in 2025.
- Business Quant data shows JSPR's Change in Cash at -$22.2 million in Q4 2025, $11.4 million in Q3 2025, and -$9.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Jasper Therapeutics | 20.08 Mn | 20.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.21 Mn |
| Sep 30, 2025 | 11.39 Mn |
| Jun 30, 2025 | -9.29 Mn |
| Mar 31, 2025 | -22.84 Mn |
| Dec 31, 2024 | -20.87 Mn |
| Sep 30, 2024 | -14.32 Mn |
| Jun 30, 2024 | -11.66 Mn |
| Mar 31, 2024 | 31.59 Mn |
| Dec 31, 2023 | -16.98 Mn |
| Sep 30, 2023 | -11.95 Mn |
| Jun 30, 2023 | -13.59 Mn |
| Mar 31, 2023 | 91.15 Mn |
| Dec 31, 2022 | -12.70 Mn |
| Sep 30, 2022 | -9.86 Mn |
| Jun 30, 2022 | -9.59 Mn |
| Mar 31, 2022 | -14.23 Mn |
| Dec 31, 2021 | -16.20 Mn |
| Sep 30, 2021 | 84.15 Mn |
| Jun 30, 2021 | -6.68 Mn |
| Mar 31, 2021 | 3.60 Mn |